loadpatents
name:-0.030298948287964
name:-0.46910309791565
name:-0.022258996963501
Butora; Gabor Patent Filings

Butora; Gabor

Patent Applications and Registrations

Patent applications and USPTO patent grants for Butora; Gabor.The latest application filed is for "lipid nanoparticle compositions and methods of formulating the same".

Company Profile
9.22.36
  • Butora; Gabor - Cambridge MA
  • Butora; Gabor - Martinsville NJ
  • Butora; Gabor - Rahway NJ
  • BUTORA; Gabor - US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polynucleotides containing a morpholino linker
Grant 11,434,486 - Butora , et al. September 6, 2
2022-09-06
Lipid Nanoparticle Compositions And Methods Of Formulating The Same
App 20220273693 - Packer; Meredith ;   et al.
2022-09-01
High Purity Rna Compositions And Methods For Preparation Thereof
App 20220096521 - Hoge; Stephen ;   et al.
2022-03-31
High Purity Rna Compositions And Methods For Preparation Thereof
App 20220096522 - Hoge; Stephen ;   et al.
2022-03-31
High purity RNA compositions and methods for preparation thereof
Grant 11,202,793 - Hoge , et al. December 21, 2
2021-12-21
Sterol Purification
App 20210347810 - BUTORA; Gabor ;   et al.
2021-11-11
High purity RNA compositions and methods for preparation thereof
Grant 10,653,712 - Hoge , et al.
2020-05-19
Phosphate replacement MRNA cap analogs
Grant 10,570,388 - Butora , et al. Feb
2020-02-25
Phosphate replacement mRNA cap analogs
Grant 10,563,195 - Butora , et al. Feb
2020-02-18
Phosphate replacement mRNA cap analogs
Grant 10,428,106 - Butora , et al. October 1, 2
2019-10-01
Alternative Nucleic Acid Molecules And Uses Thereof
App 20190255194 - ROY; Atanu ;   et al.
2019-08-22
High Purity Rna Compositions And Methods For Preparation Thereof
App 20190247417 - Hoge; Stephen ;   et al.
2019-08-15
Mrna Cap Analogs And Methods Of Mrna Capping
App 20190225644 - BUTORA; Gabor ;   et al.
2019-07-25
Mrna Cap Analogs With Modified Phosphate Linkage
App 20190218546 - BUTORA; Gabor ;   et al.
2019-07-18
Trinucleotide Mrna Cap Analogs
App 20190211368 - BUTORA; Gabor ;   et al.
2019-07-11
Alternative nucleic acid molecules and uses thereof
Grant 10,286,086 - Roy , et al.
2019-05-14
Polynucleotides Containing A Morpholino Linker
App 20190078087 - BUTORA; Gabor ;   et al.
2019-03-14
High Purity Rna Compositions And Methods For Preparation Thereof
App 20180363019 - Hoge; Stephen ;   et al.
2018-12-20
Phosphate Replacement Mrna Cap Analogs
App 20180312535 - BUTORA; Gabor ;   et al.
2018-11-01
Phosphate Replacement Mrna Cap Analogs
App 20180305393 - BUTORA; Gabor ;   et al.
2018-10-25
Phosphate Replacement Mrna Cap Analogs
App 20180291055 - BUTORA; Gabor ;   et al.
2018-10-11
Polynucleotides Containing A Stabilizing Tail Region
App 20180256750 - BUTORA; Gabor ;   et al.
2018-09-13
Disulfide masked prodrug compositions and methods
Grant 9,884,886 - Butora February 6, 2
2018-02-06
2'-alkynyl substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases
Grant 9,732,111 - Bennett , et al. August 15, 2
2017-08-15
Alternative Nucleic Acid Molecules And Uses Thereof
App 20170136131 - ROY; Atanu ;   et al.
2017-05-18
Nucleoside kinase bypass compositions and methods
Grant 9,624,249 - Butora April 18, 2
2017-04-18
Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
Grant 9,512,426 - Butora , et al. December 6, 2
2016-12-06
Disulfide Masked Prodrug Compositions And Methods
App 20150315226 - Butora; Gabor
2015-11-05
Nucleoside Kinase Bypass Compositions And Methods
App 20150315221 - Butora; Gabor
2015-11-05
2'-alkynyl Substituted Nucleoside Derivatives And Methods Of Use Thereof For The Treatment Of Viral Diseases
App 20150299243 - Bennett; Frank ;   et al.
2015-10-22
Method For Rapidly Evaluating Performance Of Short Interfering Rna With Novel Chemical Modifications
App 20150132761 - Butora; Gabor ;   et al.
2015-05-14
Method for rapidly evaluating performance of short interfering RNA with novel chemical modifications
Grant 8,877,439 - Butora , et al. November 4, 2
2014-11-04
Method For Rapidly Evaluating Performance Of Short Interfering RNA With Novel Chemical Modifications
App 20120252027 - Butora; Gabor ;   et al.
2012-10-04
Ribonucleoside cyclic acetal derivatives for the treatment of RNA-dependent RNA viral infection
Grant 7,632,821 - Butora , et al. December 15, 2
2009-12-15
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
Grant 7,598,243 - Butora , et al. October 6, 2
2009-10-06
Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
Grant 7,589,085 - Butora , et al. September 15, 2
2009-09-15
C-purine nucleoside analogs as inhibitors of RNA-dependent RNA viral polymerase
Grant 7,534,767 - Butora , et al. May 19, 2
2009-05-19
Ribonucleoside Cyclic Acetal Derivatives for the Treatment of RNA-Dependent RNA Viral Infection
App 20090099126 - Butora; Gabor ;   et al.
2009-04-16
Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
Grant 7,390,803 - Butora , et al. June 24, 2
2008-06-24
Heterocyclic cyclopentyl tetrahydroisoquinoline and tetrahydropyridopyridine modulators of chemokine receptor activity
App 20080081803 - Butora; Gabor ;   et al.
2008-04-03
C-Purine Nucleoside Analogs As Inhibitors Of Rna-Dependent Rna Viral Polymerase
App 20080021047 - Butora; Gabor ;   et al.
2008-01-24
Gamma-aminoamide modulators of chemokine receptor activity
Grant 7,247,725 - Butora , et al. July 24, 2
2007-07-24
Aminocyclopentyl pyridopyrazinone modulators of chemokine receptor activity
App 20070155731 - Butora; Gabor ;   et al.
2007-07-05
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
Grant 7,230,008 - Jiao , et al. June 12, 2
2007-06-12
Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity
App 20070117797 - Goble; Stephen D. ;   et al.
2007-05-24
Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
Grant 7,166,614 - Jiao , et al. January 23, 2
2007-01-23
Tetrahydropyran heterocyclic cyclopentyl heteroaryl modulators of chemokine receptor activity
App 20060205783 - Butora; Gabor ;   et al.
2006-09-14
Tetrahydropyranyl cyclopentyl benzylamide modulators of chemokine receptor activity
App 20060116421 - Butora; Gabor ;   et al.
2006-06-01
Tetrahydropyranyl cyclopentyl tetrahydroisoquinoline modulators of chemokine receptor activity
App 20060089379 - Jiao; Richard ;   et al.
2006-04-27
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
App 20060030582 - DeMartino; Julie ;   et al.
2006-02-09
Gamma-aminoamide modulators of chemokine receptor activity
App 20050261325 - Butora, Gabor ;   et al.
2005-11-24
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
App 20050107422 - Jiao, Richard ;   et al.
2005-05-19
Tetrahydropyranyl cyclopentyl tetrahydropyridopyridine modulators of chemokine receptor activity
Grant 6,812,234 - Jiao , et al. November 2, 2
2004-11-02
Tetrahydropyranyl Cyclopentyl Tetrahydropyridopyridine Modulators Of Chemokine Receptor Activity
App 20040167156 - Jiao, Richard ;   et al.
2004-08-26
Cyclopentyl modulators of chemokine receptor activity
App 20020049222 - Yang, Lihu ;   et al.
2002-04-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed